Status:
UNKNOWN
Genotyping of Metastatic Colorectal Cancer Patients for Precision Medicine Clinical Trials
Lead Sponsor:
Fondazione del Piemonte per l'Oncologia
Conditions:
Metastatic Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The goal of delivering the right drug to the right cancer patient (precision medicine) requires a detailed understanding of how genomic alterations are linked to drug response. The purpose of this stu...
Eligibility Criteria
Inclusion
- Histological confirmed adenocarcinoma of the colon or rectum with metastatic disease not amenable to salvage surgery.
- Planned primary treatment at FUNNEL center or FUNNEL center referring Hospital.
- Availability of fresh tissue or a paraffin block for genotyping NOT older than 1 year.
- Age ≥18.
- ECOG PS 0-1.
- No major comorbidities that would preclude the potential enrolment of the patient in a clinical trial.
- Signed informed consent.
Exclusion
- Symptomatic brain metastases.
- Gastro-intestinal abnormalities, inability to take oral medication, any condition affecting absorption.
- History of another neoplastic disease (except basal cell carcinoma of the skin or uterine cervix carcinoma in situ adequately treated), unless in remission for ≥ 5 years.
- No major comorbidities that would preclude the potential enrolment of the patient in a clinical trial.
Key Trial Info
Start Date :
October 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03350412
Start Date
October 1 2015
End Date
December 1 2019
Last Update
October 30 2018
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
AOU Policlinico S Orsola - Malpighi
Bologna, Italy
2
Policlinico S.Orsola Malpighi
Bologna, Italy
3
Fondazione del Piemonte per l'Oncologia
Candiolo, Italy, 10060
4
IOV - Istituto Oncologico Veneto
Padua, Italy